The industrial revolution has not spared the healthcare sector, as it has made the sector to realize the ultimate usage of biobanks, which otherwise were just used cold storage for a biological sample. Presently, biopharma awareness has spread among people like a wildfire and every individual is conscious about the precision of medicine they consume and thus, the biopharma industry is making a transition and this has a massive impact on the biobanking technology developers.

The biobanking had a few basic activities like collecting, processing, preserving, and storing biological samples such as blood, tissues, bodily fluids, prokaryotic and eukaryotic cells, isolated biomolecules along with its other essential raw materials that are used the research and development. However, healthcare is looking for more advanced reactive treatment for disease symptoms to come up with proactive healthcare services to treat the patients with the cause and bring in a new preventative approach to deliver better outcomes.

The healthy tissue storage for a longer duration is the most commendable discovery in medical science. However, its demand is rapidly rising as the storage of stem cells. These biobanks came into existence to support and promote biomedical research, eventually, they evolved. The ultimate purpose of the biobanks is to empower biomedical studies focusing mainly on the analysis and improvement of knowledge of condition on the various types of deadly diseases.

Biobanks’ Role in Rheumatology Research
Rheumatic disease is one of the most researched diseases in biomedicine and to carry out the research properly the basic essential includes high-quality biological samples that are associated accurately with clinical information, as well as meet the highest ethical standards and patient autonomy required that are set according to the law. Thus, biobanks have revolutionized the way regular researches are carried out.

After the intervention of biobanks has provided adequate structures that have generated great fragmentation and enhanced efficiency in the collection and storage of samples. Alongside it aids in obtaining the most associated information. This has helped the researchers by collecting various medical samples that are related to the rheumatic research these samples are collected for several years from different technicians and safely stored in the biobanks.
The biobanks are could be utilized to counter the issues that arise during the research. They aid in structuring and improve the ability of groups to tackle more ambitious scientific projects or the development of cooperative research. Alongside, the creation of well-structured sample biobanks associated with rheumatology patients could help in the development of these projects, by contributing guidance for major scientific achievements as well as helping to adapt the research developed to current legislation.

Currently, Rheumatology is dedicated to a wide range of diseases, about 13 to 15, and most unknown etiology and pathophysiological mechanisms that are not well defined. However, the current classification of these diseases is purely clinical based on signs, symptoms, progression and more. Thus, it would be essential to try to develop an etiopathogenic or pathophysiological classification using genetic studies in phenotypically well-defined patients.

The opportunity that biobanks brings in count on the samples from each patient in different formats be it solid, liquid or so, and at different times of the progression of the disease starting from diagnosis, progression, pre or post-treatment and so on, may serve to elucidate the mechanisms involved in various pathologies associated with this branch.

Therefore, biobanks could aid in using different approaches such as proteomics, genomics, and other researches by simplifying its process and support in design new target molecules for the development of drugs and other therapies.